US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 7.520
  • +0.170+2.31%
Close Nov 27 16:00 ET
  • 7.890
  • +0.370+4.92%
Post 20:01 ET
234.14MMarket Cap-2827P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-76.66%-17.32M
-52.58%-13.9M
-50.42%-17.08M
-41.58%-42.64M
-32.20%-12.37M
-50.38%-9.81M
-56.46%-9.11M
-34.91%-11.36M
-115.40%-30.12M
-157.90%-9.35M
Net income from continuing operations
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Depreciation and amortization
88.72%251K
76.74%228K
79.20%224K
47.25%536K
19.20%149K
14.66%133K
65.38%129K
177.78%125K
883.78%364K
861.54%125K
Other non cash items
19.19%236K
17.44%229K
17.28%224K
6.43%778K
3.19%194K
7.61%198K
7.73%195K
7.30%191K
-36.10%731K
-6.93%188K
Change In working capital
17.42%2.16M
-23.01%1.97M
-786.51%-3.81M
631.20%8.14M
323.09%4.17M
-19.59%1.84M
616.13%2.56M
70.57%-430K
-567.07%-1.53M
-1,424.11%-1.87M
-Change in prepaid assets
491.89%290K
-80.82%273K
-76.39%140K
159.62%2.11M
106.73%168K
-105.10%-74K
188.28%1.42M
167.08%593K
-363.22%-3.54M
-295.40%-2.5M
-Change in payables and accrued expense
58.10%3.32M
45.39%1.92M
-342.57%-3.75M
153.63%6.78M
423.63%4.21M
107.52%2.1M
3.28%1.32M
-101.43%-848K
60.70%2.67M
-22.32%804K
-Change in other current liabilities
-45.86%-264K
-21.08%-224K
-13.71%-199K
-13.04%-754K
-21.02%-213K
-5.85%-181K
-12.80%-185K
-12.18%-175K
-16.61%-667K
33.08%-176K
Cash from discontinued investing activities
Operating cash flow
-76.66%-17.32M
-52.58%-13.9M
-50.42%-17.08M
-41.58%-42.64M
-32.20%-12.37M
-50.38%-9.81M
-56.46%-9.11M
-34.91%-11.36M
-115.40%-30.12M
-157.90%-9.35M
Investing cash flow
Cash flow from continuing investing activities
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
135.80%50.72M
121.60%20.54M
103.36%1.52M
1,900.56%19.34M
2,347.47%9.33M
-59,427.73%-141.68M
-69,291.97%-95.07M
Net PPE purchase and sale
---989K
-22.32%-137K
-3,160.00%-815K
40.54%-1.29M
-358.57%-1.15M
--0
89.57%-112K
93.98%-25K
-810.08%-2.17M
-83.21%-251K
Net investment purchase and sale
1,021.37%17M
-551.96%-87.91M
-28.73%6.67M
137.28%52.01M
122.87%21.69M
103.39%1.52M
--19.45M
--9.35M
---139.51M
---94.82M
Cash from discontinued investing activities
Investing cash flow
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
135.80%50.72M
121.60%20.54M
103.36%1.52M
1,900.56%19.34M
2,347.47%9.33M
-59,427.73%-141.68M
-69,291.97%-95.07M
Financing cash flow
Cash flow from continuing financing activities
-2,028.21%-1.5M
32,446.17%123.35M
-172K
-101.53%-1.55M
-101.97%-2.01M
155.71%78K
379K
0
-9.37%101.71M
2.11%101.86M
Net common stock issuance
--0
----
----
--0
--0
--0
----
----
--104.46M
----
Proceeds from stock option exercised by employees
--0
15,734.83%60.01M
--79K
3,129.17%775K
--318K
225.00%78K
--379K
--0
2,300.00%24K
--0
Net other financing activities
---1.5M
---6.66M
---251K
16.01%-2.33M
----
----
----
----
---2.77M
---2.6M
Cash from discontinued financing activities
Financing cash flow
-2,028.21%-1.5M
32,446.17%123.35M
---172K
-101.53%-1.55M
-101.97%-2.01M
155.71%78K
3,545.45%379K
--0
-9.37%101.71M
2.11%101.86M
Net cash flow
Beginning cash position
20.65%46.43M
-10.23%25.02M
21.81%36.43M
-70.09%29.91M
-6.77%30.27M
-54.32%38.48M
-69.42%27.88M
-70.09%29.91M
4,924.67%99.99M
711.29%32.47M
Current changes in cash
65.71%-2.82M
101.82%21.4M
-461.82%-11.41M
109.31%6.52M
340.49%6.16M
84.14%-8.21M
253.50%10.61M
77.02%-2.03M
-171.51%-70.08M
-102.67%-2.56M
End cash Position
44.07%43.61M
20.65%46.43M
-10.23%25.02M
21.81%36.43M
21.81%36.43M
-6.77%30.27M
-54.32%38.48M
-69.42%27.88M
-70.09%29.91M
-70.09%29.91M
Free cash flow
-86.74%-18.31M
-52.21%-14.04M
-57.25%-17.9M
-36.07%-43.93M
-40.73%-13.52M
-41.15%-9.81M
-33.72%-9.22M
-28.86%-11.38M
-127.03%-32.28M
-155.18%-9.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -76.66%-17.32M-52.58%-13.9M-50.42%-17.08M-41.58%-42.64M-32.20%-12.37M-50.38%-9.81M-56.46%-9.11M-34.91%-11.36M-115.40%-30.12M-157.90%-9.35M
Net income from continuing operations -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Depreciation and amortization 88.72%251K76.74%228K79.20%224K47.25%536K19.20%149K14.66%133K65.38%129K177.78%125K883.78%364K861.54%125K
Other non cash items 19.19%236K17.44%229K17.28%224K6.43%778K3.19%194K7.61%198K7.73%195K7.30%191K-36.10%731K-6.93%188K
Change In working capital 17.42%2.16M-23.01%1.97M-786.51%-3.81M631.20%8.14M323.09%4.17M-19.59%1.84M616.13%2.56M70.57%-430K-567.07%-1.53M-1,424.11%-1.87M
-Change in prepaid assets 491.89%290K-80.82%273K-76.39%140K159.62%2.11M106.73%168K-105.10%-74K188.28%1.42M167.08%593K-363.22%-3.54M-295.40%-2.5M
-Change in payables and accrued expense 58.10%3.32M45.39%1.92M-342.57%-3.75M153.63%6.78M423.63%4.21M107.52%2.1M3.28%1.32M-101.43%-848K60.70%2.67M-22.32%804K
-Change in other current liabilities -45.86%-264K-21.08%-224K-13.71%-199K-13.04%-754K-21.02%-213K-5.85%-181K-12.80%-185K-12.18%-175K-16.61%-667K33.08%-176K
Cash from discontinued investing activities
Operating cash flow -76.66%-17.32M-52.58%-13.9M-50.42%-17.08M-41.58%-42.64M-32.20%-12.37M-50.38%-9.81M-56.46%-9.11M-34.91%-11.36M-115.40%-30.12M-157.90%-9.35M
Investing cash flow
Cash flow from continuing investing activities 956.13%16.01M-555.29%-88.04M-37.28%5.85M135.80%50.72M121.60%20.54M103.36%1.52M1,900.56%19.34M2,347.47%9.33M-59,427.73%-141.68M-69,291.97%-95.07M
Net PPE purchase and sale ---989K-22.32%-137K-3,160.00%-815K40.54%-1.29M-358.57%-1.15M--089.57%-112K93.98%-25K-810.08%-2.17M-83.21%-251K
Net investment purchase and sale 1,021.37%17M-551.96%-87.91M-28.73%6.67M137.28%52.01M122.87%21.69M103.39%1.52M--19.45M--9.35M---139.51M---94.82M
Cash from discontinued investing activities
Investing cash flow 956.13%16.01M-555.29%-88.04M-37.28%5.85M135.80%50.72M121.60%20.54M103.36%1.52M1,900.56%19.34M2,347.47%9.33M-59,427.73%-141.68M-69,291.97%-95.07M
Financing cash flow
Cash flow from continuing financing activities -2,028.21%-1.5M32,446.17%123.35M-172K-101.53%-1.55M-101.97%-2.01M155.71%78K379K0-9.37%101.71M2.11%101.86M
Net common stock issuance --0----------0--0--0----------104.46M----
Proceeds from stock option exercised by employees --015,734.83%60.01M--79K3,129.17%775K--318K225.00%78K--379K--02,300.00%24K--0
Net other financing activities ---1.5M---6.66M---251K16.01%-2.33M-------------------2.77M---2.6M
Cash from discontinued financing activities
Financing cash flow -2,028.21%-1.5M32,446.17%123.35M---172K-101.53%-1.55M-101.97%-2.01M155.71%78K3,545.45%379K--0-9.37%101.71M2.11%101.86M
Net cash flow
Beginning cash position 20.65%46.43M-10.23%25.02M21.81%36.43M-70.09%29.91M-6.77%30.27M-54.32%38.48M-69.42%27.88M-70.09%29.91M4,924.67%99.99M711.29%32.47M
Current changes in cash 65.71%-2.82M101.82%21.4M-461.82%-11.41M109.31%6.52M340.49%6.16M84.14%-8.21M253.50%10.61M77.02%-2.03M-171.51%-70.08M-102.67%-2.56M
End cash Position 44.07%43.61M20.65%46.43M-10.23%25.02M21.81%36.43M21.81%36.43M-6.77%30.27M-54.32%38.48M-69.42%27.88M-70.09%29.91M-70.09%29.91M
Free cash flow -86.74%-18.31M-52.21%-14.04M-57.25%-17.9M-36.07%-43.93M-40.73%-13.52M-41.15%-9.81M-33.72%-9.22M-28.86%-11.38M-127.03%-32.28M-155.18%-9.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data